Table 1.
Successful outcome | No successful outcome | |
No. of patients | 15 | 5 |
Age (yr) | 67 (55-91.2) | 63.4 (54.8-69.8) |
BMI | 24.9 (17.3-31.2) | 24.5 (19.7-28.9) |
Male:female ratio | 10:5 | 3:2 |
Neoadjuvant treatment | ||
None | 10 | 4 |
Radiotherapy | 1 | 0 |
Chemo/radiotherapy | 4 | 1 |
Indication | ||
Anastomotic leakage | 12 | 5 |
Rectal stump insufficiency | 3 | 0 |
Interval between primary operation and anastomotic leakage (d) | 12.5 (3-668) | 42 (21-668) |
Duration of endo-sponge therapy (d) | 21 (7-56) | 21 (19-106) |
Chemotherapy after endo-sponge therapy | 3 | 1 |
Follow up time (mo) | 16.1 (1.5-29.8) | 17.1(8.38-26.2) |
Interval between final endo-sponge therapy and recurrent abscess (d) | 240 (21-730) | |
Local tumor recurrence | 1 | 1 |
Values are given as absolute numbers and frequencies (%) or as medians (min-max). BMI: Body mass index.